Proton pump inhibitors and histamine-2 receptor antagonists in the intensive care setting: focus on therapeutic and adverse events

Robert MacLarenUniversity of Colorado, Skaggs School of Pharmacy and Pharmaceutical Sciences, Department of Clinical Pharmacy, C238, 12850 East Montview Blvd, Aurora, CO 80045, USA+1 303 724 2622; +1 303 724 0979; [email protected]

, PharmD MPH FCCM FCCP (Professor) ,

Lynn E KasselUniversity of Missouri Kansas City, School of Pharmacy at MU, Department of Pharmacy Practice and Administration, 701 S. Fifth St. 816 Lewis Hall, Columbia, MO 65211, USA

, PharmD (Clinical Assistant Professor) ,

Tyree H KiserUniversity of Colorado, Skaggs School of Pharmacy and Pharmaceutical Sciences, Department of Clinical Pharmacy, C238, 12850 East Montview Blvd, Aurora, CO 80045, USA

, PharmD (Associate Professor) &

Douglas N FishUniversity of Colorado, Skaggs School of Pharmacy and Pharmaceutical Sciences, Department of Clinical Pharmacy, C238, 12850 East Montview Blvd, Aurora, CO 80045, USA+1 303 724 2622; +1 303 724 0979; [email protected]

, PharmD FCCM FCCP (Professor)

Proton pump inhibitors and histamine-2 receptor antagonists in the intensive care setting: focus on therapeutic and adverse events

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Proton pump inhibitors and histamine-2 receptor antagonists in the intensive care setting: focus on therapeutic and adverse events

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date